THERAtRAME
Liège, BE · Founded 2022 · 16 employees on LinkedIn · 2 known investors
Find your way into THERAtRAME
98 people in our graph share verified history with the THERAtRAME team — schools, employers, funds. One of them is your warm intro.
Giovanni Mariggiunlockedknows Pierre Close · together at Cancerresearchuk (overlapped)
×3knows the team · via Cancerresearchuk
×6knows the team · via University of Rome Tor Vergata
knows the team · via Università di Pisa
knows the team · via Université de Liège
THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments. The company translates research on tRNA biology and modifications into first-in-class drug candidates to address therapeutic resistance and tumor progression.
Founders & leadership
THERAtRAME was founded in 2022 by Francesca Rapino and Pierre Close.
FR
Francesca RapinoinCEOFrancesca Rapino holds an ERC fellowship and previously directed the Lab of Cancer Stemness at the University of Liège; she is now CEO and cofounder of THERAtRAME, a biotech company developing tRNA-targeting therapies for cancer.
PC
Pierre CloseinCSOHe previously held a Research Director role where he contributed to understanding tRNA modifications and mRNA translation in cancer biology and immune evasion.
Investors · 2
In the news
Frequently asked questions
- What does THERAtRAME do?
- THERAtRAME is a biotech company developing tRNA-targeting therapies for cancer patients, particularly those resistant to current treatments. The company translates research on tRNA biology and modifications into first-in-class drug candidates to address therapeutic resistance and tumor progression.
- Who founded THERAtRAME?
- THERAtRAME was founded by Francesca Rapino, Pierre Close in 2022.
- Who are THERAtRAME's investors?
- THERAtRAME's investors include Wallonie Entreprendre, Qbic Fund.
- Where is THERAtRAME headquartered?
- THERAtRAME is headquartered in Liège, BE.